Harpoon Therapeutics, Inc.
DelistedCIK 1708493fmd_0QERY5SY92WX97VW2KFYCZ9JA4Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2016 to Sep 30, 2023, 28 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | 1 | 5 | 6 | 17 | 24 | 32 |
| Research and development | 8 | 14 | 26 | 42 | 53 | 72 | 81 |
| Total operating expenses | 11 | 17 | 32 | 64 | 69 | 140 | 100 |
| Operating income | (11) | (17) | (28) | (58) | (51) | (117) | (68) |
| Interest expense | 0 | 0 | – | – | – | – | – |
| Interest and investment income | 0 | 0 | 0 | 3 | 1 | 0 | 1 |
| Income tax expense | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (11) | (17) | (27) | (56) | (50) | (117) | (68) |